CAS 35231-44-8|4-(Bromomethyl)-7-methoxy-2H-chromen-2-one
| Common Name | 4-(Bromomethyl)-7-methoxy-2H-chromen-2-one | ||
|---|---|---|---|
| CAS Number | 35231-44-8 | Molecular Weight | 269.091 |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 385.3±42.0 °C at 760 mmHg |
| Molecular Formula | C11H9BrO3 | Melting Point | 213-215 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 186.8±27.9 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 4-Bromomethyl-7-methoxycoumarin |
|---|---|
| Synonym | More Synonyms |
BiologicalActivity
| Description | Br-Mmc (4-Bromomethyl-7-methoxycoumarin) is often used as fluorescent label for the determination of compounds possessing a carboxylic group. Br-Mmc is used for the determination fatty acids by TLC or HPLC[1][2][3]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Wolf JH, et al. 4-Bromomethyl-7-methoxycoumarin and analogues as derivatization agents for high-performance liquid chromatography determinations: a review. J Pharm Biomed Anal. 1992 Feb-Mar;10(2-3):99-107. [2]. Wang K, et al. Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry. J Am Soc Mass Spectrom. 1998 Sep;9(9):970-6. [3]. Hagen V, et al. Synthesis, photochemistry and application of (7-methoxycoumarin-4-yl)methyl-caged 8-bromoadenosine cyclic 3',5'-monophosphate and 8-bromoguanosine cyclic 3',5'-monophosphate photolyzed in the nanosecond time region. J Photochem Photobiol B. 1999 Nov-Dec;53(1-3):91-102. |
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 385.3±42.0 °C at 760 mmHg |
| Melting Point | 213-215 °C(lit.) |
| Molecular Formula | C11H9BrO3 |
| Molecular Weight | 269.091 |
| Flash Point | 186.8±27.9 °C |
| Exact Mass | 267.973511 |
| PSA | 39.44000 |
| LogP | 2.73 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.595 |
| InChIKey | CTENSLORRMFPDH-UHFFFAOYSA-N |
| SMILES | COc1ccc2c(CBr)cc(=O)oc2c1 |
| Storage condition | 2-8°C |
| Stability | Stable, but moisture and light-sensitive. Combustible. Incompatible with strong oxidizing agents. |
| Water Solubility | insoluble |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36-S37/39 |
| RIDADR | 1759 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 2932209090 |
Customs
| HS Code | 2932209090 |
|---|---|
| Summary | 2932209090. other lactones. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles83
More Articles| Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer. BMC Cancer 14 , 887, (2014) Bevacizumab improves progression free survival (PFS) and overall survival (OS) in metastatic colorectal cancer patients however currently there are no biomarkers that predict response to this treatmen... | |
| Characterization of adipose tissue-derived stromal vascular fraction for clinical application to cartilage regeneration. In Vitro Cell. Dev. Biol. Anim. 51(2) , 142-50, (2015) Bone marrow concentration (BMC) is the most recognized procedure to prepare mesenchymal stem cells for cartilage regeneration. However, bone marrow aspiration is highly invasive and results in low ste... | |
| Effect of codon adaptation on codon-level and gene-level translation efficiency in vivo. BMC Genomics 15 , 1115, (2014) There is a significant difference between synonymous codon usage in many organisms, and it is known that codons used more frequently generally showed efficient decoding rate. At the gene level, howeve... |
Synonyms
| (4-BroMoMethyl-7-MethoxycouMarin) |
| EINECS 252-448-3 |
| 7-methoxy-4-bromomethyl-2H-chromen-2-one |
| 4-bromomethyl-7-methoxy-chromen-2-one |
| 2H-1-Benzopyran-2-one, 4-(bromomethyl)-7-methoxy- |
| 4-Bromomethyl-7-methoxycoumain |
| 7-Methoxy-4-bromomethylcoumarin |
| 4-BROMOETHYL-7-METHOXYCOUMARIN |
| 4-(Bromomethyl)-7-methoxycoumarin |
| 4-bromomethyl-7-hydroxycoumarin |
| MFCD00006869 |
| BMC |
| BMC,Br-Mmc |
| 4-(Bromomethyl)-7-methoxy-2H-chromen-2-one |
| Br-MMc |
